login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Endovascular treatment for diabetic foot syndrome shows nearly 83% freedom from amputation


Thursday, 20 Oct 2011 13:51

A study first published online on 12 September in the Journal of Interventional Cardiology suggests that endovascular treatment of diabetic foot syndrome using mixed coronary and peripheral materials and techniques leads to high immediate success and limb salvage rates compared to historical series.


Authors of the study, Paolo Cardaioli, department of Interventional Cardiology, University of Padova Medical School, Padova, Italy et al set out to assess the long-term results of interventional treatment of diabetic foot using mixed coronary and peripheral equipments and techniques.


A diabetic foot exhibits any pathology that results directly from diabetes mellitus or any chronic complication of diabetes mellitus. Presence of several characteristic diabetic foot pathologies is called diabetic foot syndrome. Interventional treatment for the diabetic foot is rapidly becoming the therapy of choice for patients, but proper materials and techniques are still debated, wrote the authors.


The investigators prospectively enrolled 220 diabetic patients (78.5±15.8 years, 107 female, all with Fontaine III or IV class) from January 2006 to December 2010 who were referred to our center for diabetic foot syndrome and severe limb ischaemia. They used techniques using both coronary and peripheral guidewires and balloons. Doppler ultrasonography and foot transcutaneous oxygen pressure (TcPO2) before and after the procedure were calculated as well as the amputation rate.


Cardaioli et al point out that the preferred approach was ipsilateral femoral antegrade in 170/220 patients (77.7%), contralateral cross-over in 40/220 patients (18.8%), and popliteal retrograde plus femoral antegrade in 10/220 patients (4.5%).


They explain that the techniques included combined use of coronary and dedicated peripheral guidewires and coronary and peripheral dedicated balloons. “Percutaneous balloon angioplasty was performed in 252 legs, and contributing to these were 32 patients with bilateral disease. The procedure was successful in 239/252 legs with an immediate success rate of 94.8% and a significant improvement in TcPO2 and ankle-brachial index with ulcer healing in 233/252 legs (92.4%).” Authors wrote that the freedom from major amputation was 82.8% at a mean follow-up of 3.1±1.8 years (range one to five years).




Add New Comment

Related Items


Most popular


OVER analysis: Endoleak does not predict reduced long-term survival but negatively impacts sac regression
Wednesday, 18 Jun 2014
An analysis of the OVER trial presented at the Society for Vascular Surgery Vascular Annual Meeting (SVS, 5–7 June, Boston, USA) shows that the development of endoleaks were common in patients ... OVER analysis: Endoleak does not predict reduced long-term survival but negatively impacts sac regression

Medtronic to acquire Covidien for US$42.9 billion in cash and stock
Monday, 16 Jun 2014
The acquistion creates a medical technology and services company with a comprehensive product portfolio and broad global reach. Medtronic to acquire Covidien for US$42.9 billion in cash and stock

FDA advisory panel unanimously recommends approval for Lutonix DCB
Friday, 13 Jun 2014
Lutonix DCB is one step closer to becoming the first US FDA-approved drug-coated balloon for the treatment of patients with femoropopliteal occlusive disease. FDA advisory panel unanimously recommends approval for Lutonix DCB

Features


The 11th Scientific Meeting of the Chinese Society of Interventional Radiology successfully held in Changsha
Tuesday, 08 Jul 2014
The 11th Scientific Meeting of the Chinese Society of Interventional Radiology (2014 CSIR) was held from 11–15 June 2014 in Changsha, Hunan Province, China. The Chinese Society of Interventional R... The 11th Scientific Meeting of the Chinese Society of Interventional Radiology successfully held in Changsha

Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy
Tuesday, 08 Jul 2014
Unintended non-target delivery of embolic agents into any of the various hepaticoentric arteries that course from an intrahepatic artery to implant into an extra hepatic organ such as the stomach or ... Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy

Profiles


Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

James B Spies
Friday, 16 May 2014
The evolution of embolization over the past decade has been remarkable and it has fundamentally ... James B Spies

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions